ApoE Genetic Testing
Apolipoprotein E (ApoE) Genotype Testing
Genetic test for ApoE allele variants (e2, e3, e4) that significantly influence Alzheimer's disease risk and lipid metabolism. ApoE4 carriers (25% of population) have 3-15x higher Alzheimer's risk. Results guide personalized prevention strategies for brain health and cardiovascular risk.
📊 Evidence by Outcome
Alzheimer's risk assessment
3 studies • Consistency: Moderate • Effect: Moderate
Personalized prevention plan
3 studies • Consistency: Moderate • Effect: Moderate
Lipid metabolism insights
3 studies • Consistency: Moderate • Effect: Moderate
Dietary optimization guidance
3 studies • Consistency: Moderate • Effect: Moderate
Key Research
Peer-Reviewed Evidence • 1 Citations
ApoE4 and Alzheimer's Disease Risk
••2021
Key Finding: ApoE4 heterozygotes have ~3x and homozygotes have ~12-15x increased risk of late-onset Alzheimer's compared to e3/e3 genotype
Citations sourced from PubMed, Cochrane Library, and peer-reviewed journals. Study findings are summarized for accessibility. Always consult the original publication for full methodology and results.
📋 Protocol Snapshot
Protocols are for informational purposes only. Always consult a qualified healthcare provider before starting any treatment protocol.
Cost Guide
$50-200
Estimated UAE pricing. Costs vary by provider, dosage, and treatment plan.
Related Treatments
Medical Disclaimer: The information on this page is for educational purposes only and is not intended as medical advice. Kamura Scores reflect a combination of research evidence, community data, and other factors — they are not clinical recommendations. Research citations are provided for reference; always consult the original publications for complete study details. Consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Individual results may vary.